Otsuka Pharmaceutical to invest 100 billion won in Korea

Published: 2009-09-14 06:56:00

Updated: 2009-09-14 06:56:00

Otsuka Pharmaceutical Co., one of Japan's leading drug companies, will invest around 100 billion won in Korea on research and development activities over the next five years.

The company president Iwamoto and Korea's Health and Welfare Minister Jeon Jae-hee signed a memorandum of understanding...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK